Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diagnostics - search results
If you're not happy with the results, please do another search
PAVE: Global research study on epidemiology of Alzheimer’s disease
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
These four tools could enable the future of AI in healthcare
Craig Rhodes, EMEA Industry Lead, AI for Healthcare and Life Sciences, NVIDIA, argues that just four tools could enable the future of AI in healthcare.
Key to faster diagnosis for lung conditions in the NHS
Misdiagnoses and delays are far too common for people with lung conditions. Rachel Warren, Senior Policy Officer at Asthma + Lung UK and Policy Lead (Diagnosis) at the Taskforce for Lung Health, explores how new community diagnostic centres could help tackle this issue.
Keeping up to date with the symptoms of monkeypox
There are important differences in the symptoms of monkeypox between the current outbreak and previous outbreaks in endemic regions.
Computerized DNA motors are moving molecular robotics to the next level
Researchers have developed DNA motors with the ability to sense and process chemical information – mimicking the basic properties of living cells
Seegene develops monkeypox PCR test
South Korea's leading molecular diagnostics (MDx) company Seegene Inc. has developed a PCR to detect positive cases of monkeypox virus within 90 minutes.
It’s time for a public sector digital revolution
Recognising the opportunity to change the way it supports and serves citizens, the public sector digital revolution can advance all parts of society.
Who will pay for the precision cancer medicine revolution?
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Ketil Widerberg – Oslo Cancer Cluster
Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster and Chairman of Oslo Cancer Cluster Incubator
Widerberg builds on a long experience in realising new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.
Widerberg has broad operational experience ranging...
A new generation of testing for cancer: tools for navigating data in clinical decision...
Utilising early cancer detection: Are we getting the most out of first order tests for symptomatic cancer patients?
Multiple sclerosis facts & trends
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, walks us through multiple sclerosis facts & trends.
Beating lung cancer with the AI edge
Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.
Novacyt is powering ahead and tackling emerging health concerns
Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
ScanBox: Thinking inside the box for NHS diagnostic services
NHS diagnostic services have been placed under immense pressure by the COVID-19 pandemic, now, Fairford Medical’s CT ScanBoxes can ease up resource burdens
Using AI to support decision making & transform outcomes for stroke patients
Adam Nickerson, Head of Category, Digital and IT procurement frameworks at NHS Shared Business Services (NHS SBS), explains how artificial intelligence software (AI) is used to support decision making & transform outcomes for stroke patients.
What we need to make breakthroughs in dementia research
David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.
WHO licensing agreement can improve access to COVID health technologies
The WHO licensing agreement with the Medicines Patent Pool (MPP) and US National Institutes of Health (NIH) should improve access to some COVID health technologies, like early-stage vaccines and diagnostic tools.
Are Community Diagnostic Hubs the way forward?
Medispace, a provider of fully equipped MRI trailers and CT trailers, looks to the future of community diagnostic hubs, advocating for much-needed changes to be implemented.
Can predictive genomics make our healthcare systems more sustainable?
Dr Zisis Kozlakidis with Francesco Florindi, discuss predictive genomics and ask if it can help make our healthcare systems more sustainable.
European innovation potential knows no bounds
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, calls attention to building a pan-European innovation potential ecosystem in health served with top-notch infrastructures.
